Empirical Radioactive Iodine Therapy in DTC

Starting soon · Phase 1/Phase 2

Conditions studied: Differentiated Thyroid Cancer

In brief

The aim of the study is assessment the efficacy of empiric RAI therapy in DTC patients with elevated thyroglobulin levels and negative iodine scintigraphy.

Key facts

Study ID

NCT07453225

Run by

Assiut University

People needed

100

Starts

2026-04-01

Expected to finish

2028-07-01

Last updated by the study team

2026-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• This study will include adult patients with pathologically proved DTC who underwent total thyroidectomy and received RAI therapy presented to our nuclear medicine unit with evidence of persistent or recurrent biochemical disease during follow up.

You may not qualify if…

• Undifferentiated thyroid cancer.
• Patients with evidence of structural disease.
• Patients less than 18 years old.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.